Objective: Antioxidants, in particular carotenoids, may in¯uence the risk for cardiovascular disease. This study investigates the in¯uence of oral contraceptives (OC) on the serum concentration of beta-carotene, which may in turn affect the risk of cardiovascular diseases due to its antioxidative impact. Design: Cross-sectional epidemiologic study. Examinations included a detailed questionnaire on medical history and lifestyle factors, a 7 day food record, and blood samples. Setting: National health and nutrition survey among healthy people living in private homes in West Germany in 1987±1988. Subjects: Nonpregnant and nonlactating women aged 18±44 (n 610). Results: Overall, the use of OC was negatively associated with serum beta-carotene concentration in bi-and multivariable analyses after adjustment for age, smoking, alcohol consumption, dietary intake of beta-carotene, use of vitamin supplements, body mass index, pregnancies, and serum concentrations of total triglyceride and cholesterol. A strong interaction between OC use and age on beta-carotene concentration was observed. While no relationship between OC use and serum beta-carotene was seen in the youngest age-group (18±24 y), there was a modest but signi®cant negative association between OC use and beta-carotene levels among 25±34 y old women. The use of OC was associated with a strong decrease in beta-carotene levels among 35±44 y old women. The interaction between OC use and age could partly be explained by age dependent use of OC with higher estrogen content. Conclusions: OC use seems to be strongly related to serum beta-carotene levels, particularly among women above the age of 35. Further studies are needed to clarify the underlying mechanisms of this association and its implications for health risks of OC use. Sponsorship: The national health and nutrition survey was founded by the German Ministry of Research and Technology.
Introduction
Taking oral contraceptives (OC) appears to be an important risk factor causing higher vascular morbidity and mortality in women, particularly venous thromboembolism (Realini and Goldzieher, 1985; Kalin and Zumoff, 1990; Grimes, 1992; La Veccia, 1992) , although results of epidemiologic studies on the risk of cardiovascular disease are not homogeneous. This heterogeneity may partly be due to manifold methodologic problems of pertinent epidemiologic studies. Furthermore, changes in the formula of OC, the increasing use of OC by young women free of cardiovascular risk factors, and ®nally the augmented overall use of OC have complicated the assessment of the risk for users (Petitti, 1986) .
The disturbance of the lipoprotein metabolism is discussed as one potential pathogenetic mechanism linking OC use with vascular disease (Godsland and Crook, 1994) . This applies particularly to the ®rst generation of OC. At the beginning of the seventies, the second generation OC with lower estrogen and progestin doses was developed (Thorogood and Vessey, 1990) . The excess risk of myocardial infarction was found to be lower with second generation OC compared to the risk associated with ®rst generation OC. Nevertheless, women using second generation OC are still exposed to a higher risk of myocardial infarction than non-users of OC. This particularly applies to women above 35 y of age and smokers (Grimes, 1992) . In the third generation new progestin-formulas like desogestrel and gestoden were introduced (Speroff and DeCherney, 1993) . Even though the latter preparations have less negative in¯uence on lipoproteins, new studies showed that the incidence of venous thromboembolism is even higher in women taking these new OC than in women using second generation OC (WHO, 1995; Jick et al, 1995; Spitzer et al, 1996) . Therefore, other mechanisms for the impact of OC on cardiovascular disease require further investigation.
Several epidemiologic studies have addressed the possible protective role of beta-carotene, a provitamin with antioxidant capacity, in the development of cardiovascular disease. The consumption of fresh fruit and vegetables containing beta-carotene has been shown to be inversely related to mortality due to coronary artery disease and to the risk of acute myocardial infarction (Palgi, 1981; Gramenzi et al, 1990) . The importance of beta-carotene serum levels in relation to these diseases has only recently been investigated. Riemersma and colleagues (1991) found a signi®cant inverse association between beta-carotene and angina pectoris in a population-based case-control study yielding an odds ration (OR) of 2.6 comparing lowest and highest quintile of beta-carotene intake. This association was strongly reduced, however, after adjustment for smoking (OR 1.4). In the EURAMIC study, Kardenaal et al, (1993) found a similar association analyzing fat tissue concentration of beta-carotene and myocardial infarction. In this study, the negative association persisted after adjustment for smoking habits. In a longitudinal study carried out in Switzerland, a signi®cantly increased risk for ischemic heart disease and stroke was found for subjects with initially low plasma levels of beta-carotene (Gey et al, 1993) . In a recent review of epidemiologic studies on the role of carotenoids in cardiovascular disease prevention Kohlmeier et al, (1995) conclude that beta-carotene intake is a good marker of the risk for cardiovascular diseases. Even though beta-carotene is discussed mostly in context of atherosclerotic processes, it might also be of interest to study its impact on the preservation of endothelial function, reduction of platelet aggregability, the alteration of ®brin formationÐfactors which could also lead to a higher risk for thrombosis (Bendich, 1993; Gaziano and Hennekens, 1993) .
Ever since the introduction of these drugs many studies have dealt with the in¯uence of OC use on changes in carbohydrate, lipid, different enzymes, mineral and vitamin metabolism (Corson, 1986 ), but few have investigated the association between OC use and serum beta-carotene. Although the ®rst study from Briggs et al, (1972) did not ®nd any association between serum beta-carotene and OC use, four studies found decreased levels of serum betacarotene among OC users in bivariate analyses (Prasad et al, 1975; Horwitt et al, 1975; Yeung, 1976; Arab et al, 1982) . In a more recent bivariate analysis, Palan and colleagues (1989) observed additive effects of OC use and smoking on the reduction of serum beta-carotene levels. None of the previous studies paid attention to the role of other potential confounders or effect modi®ers of the relation between OC use and beta-carotene. The role of covariates is of concern, however, since OC use is likely to be associated with other potential determinants of serum beta-carotene, such as sociodemographic and nutritional factors. Furthermore, none of the previous studies considered the different types of OC. The aim of the present study is to analyze the association between OC use and serum beta-carotene concentration with particular attention to the role of potentially important covariates including age, body mass index, smoking habit, alcohol consumption, nutrient intake, serum lipid concentrations, and ®nally the OC preparations. The age dependency of the impact of OC use on cardiovascular risks led us to pay particular attention to potential interaction between OC use and age.
Method

Study population
This analysis is based on a national health and nutrition survey among healthy people in Germany conducted in 1987±1988 (VERA-studyÐVerbundstudie Erna Èhrungser-hebung und Risikofaktoren Analytik, a substudy within the German Nutrition Survey; Moch, 1994) . A strati®ed random sample was drawn from the non-institutionalized population aged 18±89 y in West Germany and Berlin. With a participation rate of about 70%, 2006 men and women were recruited for this study. There were only minor differences between the study population and the target population with respect to sex and age distribution (Schneider et al, 1992) . The present analysis on the in¯uence of OC use on serum beta-carotene levels is restricted to nonpregnant and nonlactating women aged 18±44 y, who did not take other sex hormones (n 610).
Data collection
Participants were recruited during all seasons and in all regions of West Germany and Berlin. They completed a detailed questionnaire on medical history and various sociodemographic and lifestyle factors including diet, smoking habits and OC use. Nutrient intake of betacarotene and alcohol consumption were calculated from a 7 day food record using the data base of the computerized German food-code (BLS: Bundeslebensmittelschu Èssel; Kroke, 1992) . The participants were instructed in the recording of all food over a seven consecutive day period by trained staff. Records were assessed for completeness before coding. Use of vitamin supplements was de®ned as intake of at least one supplement per month. This rather crude categorization re¯ects the fact that vitamin supplement intake is not common in Germany. Age was classi®ed in three categories (18±24/25±34/35±44 y) to allow comparison to other analyses of the VERA-study and other national health surveys such as NHANES (NCHS, 1984) . Current smoking status was de®ned dichotomously. A women was de®ned as a smoker when she reported smoking one or more cigarettes per day or as nonsmoker otherwise. None of the women in these age groups reported smoking other products. The body mass index (BMI) was used as a measure of relative body weight. A distinction was made between women who had never been pregnant and women who had one pregnancy or more.
OC use was categorized into current, past and never use. Information on OC use was almost complete; only two people refused to answer the questions about their contraception methods. The estrogen contents in currently used OC was dichotomized in less than 50 mg ethylestradiol and equal to 50 mg ethylestradiol. None of the preparations listed by the participants had a higher content of ethylestradiol. Progestin compounds were classi®ed according to their chemical structure into preparations with desogestrel, levonorgestrel, lynestrenol/norethisteron or antiandrogen effective OC. The exact composition of OC was only partly given, otherwise it was classi®ed as`unknown'.
Serum concentrations of beta-carotene, total triglycerides and total cholesterol were obtained using blood samples collected under fasting conditions in heparinized tubes between 7 and 10 am. Blood samples were analyzed within two months of collection in a central laboratory. Betacarotene concentration in serum was analyzed by highperformance liquid chromatography after extraction with ethanol and hexanol and was measured photometrically. Cholesterol and triglyceride were determined with enzymatic chlorimetric assay. A detailed description of the survey methodology has been published elsewhere (Speitling et al, 1992) .
Statistical analysis
In a ®rst step, current, past and never users of OC were compared with respect to beta-carotene levels and the covariates. To avoid possible confounding by age, the percentages and medians of covariates were age-adjusted to the entire study population by the direct method (Rothman, 1986). Use of different OC preparations was assessed according to age-categories. In addition, for each of the Use of oral contraception and serum beta-carotene G Berg et al three categories odds ratios with 95% con®dence limits (CL) were calculated for the association of current use of OC with serum beta-carotene levels below 21.5 mg/dl. The cutpoint of 21.5 mg/dl re¯ects recently proposed classi®cation of desirable beta-carotene serum levels (Sta È-helin et al, 1988; Gey, 1994) . The impact of OC use and covariates (age, smoking, alcohol consumption, dietary intake of beta-carotene, use of vitamin supplements, BMI, history of pregnancy, serum concentration of cholesterol and triglycerides) on the natural logarithm of serum betacarotene concentration was assessed using simple and multiple linear regression. The aforementioned covariates which were found or suspected to be related to serum betacarotene concentration on the basis of previous studies were a priori de®ned and included in the modelling. All variables were retained in the multivariable modelling regardless of their statistical signi®cance. The log transformation was necessary because of the highly skewed distribution of serum beta-carotene concentrations. Intake of beta-carotene and other serum concentrations were likewise log-transformed. We used untransformed values for age, BMI and alcohol intake in all analyses. Because of the missing values in one or more variables, 29 of 610 women were excluded from the multivariable analysis. One value of beta-carotene concentration, which exceeded the mean by more than ®ve standard deviations even after log transformation, was regarded as an extreme and potentially in¯uential outlier and was excluded from the model. After exclusion of this outlier, the log-transformed values of serum beta-carotene concentration were close to normally distributed. Collinearity diagnostics in the multivariable models were performed using the Belsley-Kuh-Welchcriteria. Collinearity was not found to be of concern in these analyses. Finally we analysed the in¯uence of estrogen contents and progestin compounds of OC preparations on serum beta-carotene in bi-and multivariate linear regression with the same covariates.
Results Table 1 describes the age distribution of OC users and nonusers: 195 women (32% of the study population) were current users of OC, 322 women (53%) had used OC in the past, and 91 women (15%) had never used OC. Current OC users on the average were younger than past and never users. 54.5% of women at the age of 18±24 currently used OC, compared to 35.2% in the age group of 25±34 y and 12.3% in the oldest age group (35±44 y). Two thirds of current OC users were under 30 y of age. The age-adjusted distribution of covariates by OC use is summarized in Table 2 . Smoking and alcohol consumption were very common and unrelated to OC use in this study population with an overall prevalence of about 50% and 90%, respectively. A history of pregnancies was more frequent in past OC users (66.8%) than in current and never users (59.6% and 56.5%, respectively). Only 7.0% of the current OC users took vitamin supplements, as compared to 12.4% of women not taking OC. Examination of nutrient intake revealed no relevant differences between current, past and never users of OC. Current OC users had a marginally smaller intake of beta-carotene than past and never users, but there was a wide range of intake within all groups. The percentage of overweight women (BMI ! 24 kg/m 2 ) was slightly higher in never users of OC (31.6%) than in past (29.4%) and current (28.8%) users. Only a minority of women (8.9%) had a BMI below 19 kg/m 2 . Serum concentrations of beta-carotene strongly differed by OC use: The median serum level of betacarotene was lower in the group of current OC users (median: 25.1 mg/dl) than in past and never users (median: 32.5 mg/dl and 31.2 mg/dl, respectively). The median serum triglyceride concentration also varied strongly by OC use. It ranged from 66.9 mg/dl and 69.5 mg/dl in past and never users, respectively, to 91.2 mg/dl in current users. Serum concentration of total cholesterol seemed to be less affected by current OC use.
The estrogen contents and progestin compounds of the OC used in this study population are shown by agecategories in Table 3 . None of the 152 women who provided information on their OC preparations reported to take the`minipill' which only contains progestin. The OC used were in general newer preparations with lower estrogen and progestin doses. With regard to the estrogencontent, preparations containing less than 50 mg ethylestradiol were more frequently used (70% of the known preparations), especially by women aged 18±24 y (79%). In contrast, women aged 35±44 y more frequently used preparations containing 50 mg ethylestradiol. The examination of progestin-compounds showed that desogestrel was the most commonly used progestin, particularly in the youngest age group. Lynestrenol/norethisteron containing OC were less frequently used by the youngest OC users (18±24 y) than by OC users in the other age-categories.
As shown in Table 4 , 25% of the total study population with known OC use (148 of 582 women) had beta-carotene levels below the desirable value of 21.5 mg/dl. This percentage was considerably higher in current OC users (34%) than in other women (21%) yielding an overall odds ratio of Use of oral contraception and serum beta-carotene G Berg et al 1.9 (95% CL: 1.3±2.8) for the association of OC use with beta-carotene concentration below 21.5 mg/dl. Strati®cation by age showed that the association of OC use with serum beta-carotene concentration below the desirable level was much stronger among 35±44 y old women (OR: 3.4) than among age groups 18±24 y (OR: 1.5) and 25±34 y (OR: 1.9). The strong interaction between OC use and age was con®rmed in the multiple linear regression analysis. The addition of the interaction terms between OC use and age contributed signi®cantly to the prediction (P 0.008 for partial F-test). Therefore these terms were retained in the model, and the association between OC use and log-serum beta-carotene levels is shown separately by age groups for both bivariate and multiple linear regression in Table 5 . While only a small and not signi®cant relationship between OC use and serum-beta-carotene was observed in the youngest age-group (18±24 y), there was a modest, signi®cant negative association between OC use and betacarotene levels in the middle age group (25±34 y). In women aged 35±44 y, OC use was associated with a strong decrease in beta-carotene levels. We also observed a signi®cant negative relationship with serum beta-carotene of smoking, alcohol intake, BMI and triglycerides. There was a positive relationship between beta-carotene intake, cholesterol serum concentration and beta-carotene serum levels. The multivariable analysis revealed no signi®cant association of the history of pregnancies and vitamin supplement intake with beta-carotene serum concentration. Overall, 27% of the variance of the natural logarithm of serum beta-carotene was explained by the predictors included in the multivariable model. Tables 6 and 7 show the association of the estrogen contents or progestin compounds of OC with serum betacarotene levels in bivariate and multivariable regression analyses. The analysis was restricted to women above 24 y whose serum beta-carotene levels are affected by OC use. The limited sample size of our study did not allow to address potential interaction between use of speci®c OC preparations and age with adequate power. All preparations were related with a decrease of serum beta-carotene, but the decrease was much larger for OC with higher contents of ethylestradiol (50 mg) than for other OC (see Table 7 ). Different progestin compounds in OC seemed to be equally related to a decrease of serum beta-carotene concentration. An exception were levonorgestrel containing OC which were only related to a marginal non-signi®cant decrease of serum beta-carotene. Our data did not allow to distinguish the impact of estrogen content and progestin compounds on serum beta-carotene levels since both factors are highly correlated.
Discussion
This study found an inverse relation of OC use with serum beta-carotene along with a strong interaction between OC use and age. While no relationship between OC use and serum beta-carotene was observed in the youngest agegroup (18±24 y), OC use was associated with a moderate and strong decrease in beta-carotene levels in women aged 25±34 and 35±44 y, respectively. In the oldest age group, the negative association between OC use of beta-carotene was much stronger than the well known negative association between smoking and serum beta-carotene. In this age Use of oral contraception and serum beta-carotene G Berg et al group, about half of the OC users had serum levels of betacarotene below the desirable serum level of 21.5 mg/dl. This cutpoint of 21.5 mg/dl (4 mmol/l) was suggested in the Basel study and con®rmed in various epidemiologic studies (namely, MONICA Vitamin Substudy, Edinburgh Angina-Control, US-Health Professional Study, NHANES I) (Gey, 1994) . The cutpoint was proposed with regard to cancer and cardiovascular diseases. To evaluate the sensitivity of the odds ratios to the cutpoint used, we considered the median (29.9 mg/dl) as cutpoint in an additional analysis. The results were similar in relation to the age-dependent effect of OC on serum beta-carotene.
Our ®ndings con®rm those of older studies except for one (Briggs et al, 1972) which assessed associations of OC use with beta-carotene levels in bivariate analyses (Prasad et al, 1975; Horwitt et al, 1975; Yeung, 1976; Arab et al, 1982) . Another more recent bivariate analysis (Palan et al, 1989 ) also found a signi®cantly lower beta-carotene serum concentration in current OC users as well an additive effect of OC use and smoking. However, none of the previous studies strati®ed for age, nor considered additional covariates other than smoking. In particular, the potential role of speci®c OC preparations had not been addressed.
One possible mechanism which could explain the age dependency of decreased beta-carotene concentration by OC use are the different types of OC used by older women. Women above 24 y of age more often used older preparations containing higher amounts of ethylestradiol. Those are the preparations which lead to a higher decrease of serum beta-carotene concentration (Table 6 and 7) . By contrast, OC containing the older progestin compounds like lynestrenol/norethisteron lead to a similar decrease of serum beta-carotene concentration than OC containing the newest one (desogestrel).
Further investigation is needed to establish a mechanism of the in¯uence of OC use and different OC preparations on serum beta-carotene levels. In former studies (Prasad et al, 1975; Horwitt et al, 1975; Yeung, 1976) , the substantial increase of retinol under OC use is put forward as an explanation. The increase might probably be due to an activation of the production of the retinol binding protein (Mooij et al, 1991) , thus possibly increasing the conversion of beta-carotene into retinol. The effect of OC on retinol is mainly caused by estrogen and not by progestin (Anatayakul et al, 1984) , Palan and colleagues (1989) described another possible mechanism: OC use in¯uences the lowdensity lipoprotein fraction (LDL), the plasma carrier protein for beta-carotene. The effect of estrogens and progestins on the lipid metabolism is controversial and depends on their composition, therefore the increase in LDL varies with different types of OC (Fortherby, 1985) . The older generations of OC, however, which contain higher amounts of ethylestradiol and larger contents of the progestins norethisteron or levonorgestrel, were found to increase LDL-cholesterol (Burkman, 1988; Fortherby, 1985) . Furthermore, increased oxidative stress due to OC use which in turn rises serum concentration of copper, could contribute to the decrease of beta-carotene levels. Use of oral contraception and serum beta-carotene G Berg et al
The increase of serum copper depends on the estrogen content, although it was shown that levonorgestrel may reduce this effect (Song et al, 1989) . Besides the age-and preparation-dependent relationship of OC use with beta-carotene, we found a signi®cant relationship between serum beta-carotene and smoking, alcohol intake, BMI, triglycerides, nutrient intake and total cholesterol levels. These results are similar to ®ndings from other studies using multiple linear regression to analyze the determinants of beta-carotene in the population (Willett et al, 1983; Stryker et al, 1988; Roidt et al, 1988; Ascherio et al, 1992; Herbert et al, 1994; Hesker and Schneider, 1994) . These studies, which analyzed determinants of serum beta-carotene among samples including both men and women, did not address the potential role of OC use. Most studies found a signi®cant association between gender and beta-carotene serum concentrations. Three of these studies (Stryker et al, 1988; Ascherio et al, 1992; Hesker and Schneider, 1994) analyzed the determinants of serum beta carotene separate for both genders; in all cases, the proportion of the explained variance was less for women (r 2 0.25±0.29) than for men (r 2 0.30±0.42). In our study the explained variance increased from 24±27% when OC use was taken into account which implies that OC use is a factor that accounts for some of the unexplained variance among women. The use of vitamin supplements was not associated with serum beta-carotene in this study. This could possibly be explained by the small number of people taking vitamin supplements, the crude classi®cation of vitamin supplementation, as well as by the fact that many supplements do not contain beta-carotene.
An important question is whether the in¯uence of OC use on serum beta-carotene leads to health risks. In our study, a considerable percentage of OC users were also smokers, thus increasing the risk of low beta-carotene levels and the subsequent possible negative effects on health. The strong association between OC use and beta carotene in women above 35 y of age who already have a substantial risk of cardiovascular diseases (Woods, 1988) strengthens the possibility that OC use has a relevant negative impact on health by decreasing beta-carotene levels.
Conclusions
Taking OC appears to be an important determinant of serum concentrations of beta-carotene, particularly in women older than 35 y. Further studies are needed to clarify the underlying mechanisms of this association, the importance of the estrogen content in OC, and their implications for the health risks associated with OC use. From the public health point of view, it appears prudent to recommend consumption of vegetables rich in beta-carotene to women using OC. At the same time increased efforts are badly needed to reduce the high prevalence of smoking among women using OC as observed in our study. Use of oral contraception and serum beta-carotene G Berg et al
